Unlike the illicit use of anabolic steroids, IGF-1 in medicine is administered under strict supervision and is intended to address specific health concerns, such as growth hormone deficiency or sarcopenia, the age-related loss of muscle mass
The BPC-157 versus TB-500 comparison is one of the most common discussions in the peptide community, and for good reason
But important limitations exist: Most research is in animals, not humans Long-term safety beyond 12 weeks is uncharacterized Drug interactions haven't been formally studied Cancer relationship remains unclear Who should consider BPC-157: Those researching recovery support for injuries or gut issues Individuals willing to accept calculated risk with an experimental peptide People who can work with a knowledgeable healthcare provider Who should avoid it: Those with active cancer or high cancer risk Anyone on medications that might interact (especially cardiovascular, dopamine-affecting) Individuals unwilling to monitor their response carefully If you choose to use BPC-157, start conservatively (200 mcg daily), use proper injection technique, source from reputable suppliers, and track your body's response
This helps dial down the "food noise" and naturally reduce how much you eat without feeling deprived
These reports typically describe inflammatory acne lesions appearing within one to four weeks of initiating B12 therapy, with resolution following discontinuation
